Viewing StudyNCT06382948



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06382948
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-12
First Post: 2024-04-05

Brief Title: Elacestrant Everolimus in Patients ERHER2- ESR1mut Advanced Breast Cancer Progressing to ET and CDK46i
Sponsor: MedSIR
Organization: MedSIR

Conditions & Keywords Data

Conditions:
Name
ESR1 Gene Mutation
Advanced Breast Cancer
ER-positive Breast Cancer
HER2-negative Breast Cancer
Keywords:
Name View
ER-positive View
HER22-negative View
ESR1-mutation View
CDK46-inhibitor View
Selective endocrine receptor degrader SERD View